毒青类类化合物的结合和封存由血球蛋白
Aurora Alvarez-Buylla1, Marie-Therese Fischer1, Maria Dolores Moya Garzon2,3,4
1Department of Biology, Stanford University, Stanford, United States.
eLife
|January 11, 2024
概括
毒青使用一种新型的血蛋白,类化合物结合球蛋白 (ABG),来运输有毒类化合物. 这一发现揭示了蛇形蛋白在动物防御和分子运输中的新功能.
科学领域:
- 生物化学 生物化学
- 动物学 动物学
- 化学生态化学生态学
背景情况:
- 化物是自然界中重要的生物活性分子,经常作为动物的化学防御.
- 毒青积累了饮食中的类化合物,以防捕食者,但运输机制尚不清楚.
研究的目的:
- 为了确定毒青血液中主要的化物结合蛋白质.
- 描述这种蛋白质的功能和进化关系.
主要方法:
- 化学方法来识别化物结合分子.
- 蛋白质组和生物化学分析以表征蛋白质.
- 在体外研究以评估结合和封存活性.
主要成果:
- 约50kDa的血蛋白,类化合物结合型全球蛋白 (ABG) 被确定为主要的类化合物结合剂.
- ABG是一种来自肝脏的蛇形家族成员,可以隔离和调节自由等离子体化物.
- ABG显示同质性与激素载体和胆胺结合蛋白,以前未知的化物载体.
结论:
- ABG代表了一种新型的小分子结合功能,属于蛇形蛋白家族.
- 这一发现阐明了毒青血中类化合物运输的新机制.
- 蛇可以作为多功能支架,用于在各种生物体中结合和运输小分子.
相关概念视频
Drug Distribution: Plasma Protein Binding
5.6K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.6K
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Enhanced Elimination of Poison
514
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
514
Drug Binding to Blood Components
150
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
150
Prevention of Further Absorption of Poison
824
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
824
Drug Elimination by Renal Route: Tubular Reabsorption
3.4K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.4K


